Scinovex
review Open AccessTop 1% cited

Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment

Molecular Psychiatry · 2023 · Vol. 28(5) · pp. 1902–1918
Robert A. McCutcheonRichard S.E. KeefePhilip McGuire

Abstract

Cognitive deficits are a core feature of schizophrenia, account for much of the impaired functioning associated with the disorder and are not responsive to existing treatments. In this review, we first describe the clinical presentation and natural history of these deficits. We then consider aetiological factors, highlighting how a range of similar genetic and environmental factors are associated with both cognitive function and schizophrenia. We then review the pathophysiological mechanisms thought to underlie cognitive symptoms, including the role of dopamine, cholinergic signalling and the balance between GABAergic interneurons and glutamatergic pyramidal cells. Finally, we review the clinical management of cognitive impairments and candidate novel treatments.

Schizophrenia research and treatmentReceptor Mechanisms and SignalingTryptophan and brain disordersSchizophrenia (object-oriented programming)NeuroscienceCognitionGlutamatergicPsychologyPsychosisEtiologyMedicinePsychiatryGlutamate receptor

MeSH terms

CognitionCognition DisordersHumansInterneuronsSchizophreniaCognitive Dysfunction

Funding

  • National Institute for Health and Care Research
Citations
644
FWCI
143.14
field-weighted impact
References
320
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment · Scinovex